Is OKYO or OMER more undervalued in 2026?

CirclFi compares OKYO Pharma Limited (OKYO) and Omeros Corporation (OMER) using 13 institutional-grade valuation models. OKYO has a Quality of Company score of 1.7/10 while OMER scores 3.3/10.

Which is a better buy — OKYO or OMER?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OKYO and OMER valuations compare?

OKYO at $1.71 and OMER at $11.15 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OKYO vs OMER Valuation Comparison 2026 — Intrinsic Value Analysis

OKYO

Biotechnology

OKYO Pharma Limited

Quality

1.7

out of 10

Value Trap

—

Price

$1.71

Last close

Models

8/13

Active

OMER

Biotechnology

Omeros Corporation

Quality

3.3

out of 10

Value Trap

LOW

Price

$11.15

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	OKYO Fair Value	OKYO Upside	OMER Fair Value	OMER Upside
Bayesian DCF	Intrinsic	$0.45	-73.5%	$2.45	-78.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.66	-61.1%	$3.03	-72.8%
PWERM	Option-Based	$1.04	-38.7%	$2.86	-74.3%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OKYO vs OMER — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OKYO vs OMER — Which Stock Is More Undervalued?

OMER scores higher with a 3.3/10 quality rating vs OKYO's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing OKYO Pharma Limited (OKYO) and Omeros Corporation (OMER) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OKYO currently trades at $1.71 with a QOC of 1.7/10, while OMER trades at $11.15 with a QOC of 3.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).